| Description |
1 online resource |
| Series |
RSC Drug Discovery ; 4 |
|
RSC drug discovery series ; 4.
|
| Contents |
The discovery of the dipeptidyl peptidase-4 (DPP4) inhibitor Onglyza : from concept to market / Jeffrey A. Robl and Lawrence G. Hamann -- The discovery of Vorapaxar (SCH 530348), a thrombin receptor (protease activated receptor-1) antagonist with potent antiplatelet effects / Samuel Chackalamannil -- The discovery of Piragliatin, a glucokinase activator / Ramakanth Sarabu, Jefferson W. Tilley and Joseph Grimsby -- The discovery of OSI-906, a small-molecule inhibitor of the insulin-like growth factor-1 and insulin receptors / Mark J. Mulvihill and Elizabeth Buck -- The genesis of the antibody conjugate gemtuzumab ozogamicin (Mylotarg®) for acute myeloid leukemia / Philip R. Hamann -- Novel androgen receptor antagonists for the treatment of prostate cancer / Ashvinikumar V. Gavai, William R. Foster, Aaron Balog and Gregory D. Vite -- The discovery of UK-390957 : the challenge of targeting a short half-life, rapid Tmax SSRI / Mark D. Andrews and Donald S. Middleton -- The discovery of the long-acting PDE5 inhibitor PF-489791 for the treatment of pulmonary hypertension / Andrew S. Bell and Michael J. Palmer -- From HTS to market : the discovery and development of maraviroc, a CCR5 antagonist for the treatment of HIV / Chris Barber and David Pryde -- The discovery of GS-9131, an amidate prodrug of a novel nucleoside phosphate HIV reverse transcriptase inhibitor / Richard Mackman -- 2'-F-2'-C-methyl nucleosides and nucleotides for the treatment of hepatitis C virus : from discovery to the clinic / Michael J. Sofia, Phillip A. furman and William T. Symonds -- A case history on the challenges of central nervous system and dual pharmacology drug discovery / Paul V. Fish, Anthony Harrison, Florian Wakenhut and Gavin A. Whitlock -- The discovery of TRPV1 antagonists : turning up the heat / Mark H. Norman -- Uncoupling neuroprotection from immunosuppression : the discovery of ILS-920 / Edmund I. Graziani -- Identification of [alpha] 7 nicotinic acetylcholine receptor agonists for their assessment in improving cognition in schizophrenia / Bruce N. Rogers [and others] |
| Summary |
Accounts in Drug Discovery describes recent case studies in medicinal chemistry with a particular emphasis on how the inevitable problems that arise during any project can be surmounted or overcome. The Editors cover a wide range of therapeutic areas and medicinal chemistry strategies, including lead optimization starting from high throughput screening ""hits"" as well as rational, structure-based design. The chapters include ""follow-ons"" and ""next generation"" compounds that aim to improve upon first generation agents. This volume surveys the range of challenges commonly faced by medicinal |
| Notes |
Online resource; title from title screen (viewed on June 15, 2010) |
| Subject |
Drug development -- Case studies
|
|
Pharmaceutical chemistry -- Case studies
|
|
Pharmacology.
|
|
MEDICAL -- Drug Guides.
|
|
MEDICAL -- Nursing -- Pharmacology.
|
|
MEDICAL -- Pharmacology.
|
|
MEDICAL -- Pharmacy.
|
|
Drug development
|
|
Pharmaceutical chemistry
|
| Genre/Form |
Case studies
|
| Form |
Electronic book
|
| Author |
Barrish, Joel Charles, 1957-
|
|
Carter, Percy
|
|
Zahler, Robert
|
| ISBN |
9781849731980 |
|
1849731985 |
|
